3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow bromfenac: new trials by email Literature Review of bromfenac trials Research Report on bromfenac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery ISV-303, Bromday™ - Cataract | Phase 2 | Completed | Sun Pharmaceutical Industries Limited | 60 | 2011-07-01 | 2021-11-19 |
| Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers ISV-303, DuraSite Vehicle, Xibrom™ - Ocular Inflammation | Phase 1 / Phase 2 | Completed | Sun Pharmaceutical Industries Limited | 169 | 2010-08-01 | 2021-11-19 |
| Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration combination ranibizumab + bromfenac, ranibizumab injection alone - Age-Related Macular Degeneration | Phase 2 | Completed | Oregon Health and Science University | 30 | 2008-12-01 | 2011-07-22 |
Cataract (1) · Macular Degeneration (1)
Sun Pharmaceutical Industries Limited (2) · Oregon Health and Science University (1)
United States (1)